The document discusses gestational diabetes management and screening. It provides guidance on screening all pregnant women for gestational diabetes, including risk factors to consider. It recommends using a 75-gram oral glucose tolerance test (OGTT) and provides the diagnostic thresholds. Dietary management and self-monitoring of blood glucose are also covered.
Philippine CPG on Diagnosis & Screening for Gestational DiabetesIris Thiele Isip-Tan
Philippine CPG on diagnosis and screening of gestational diabetes presented for comments at the 3rd Unite for Diabetes Annual Convention this September.
Identifying women with GDM is important because appropriate therapy can decrease maternal and fetal morbidity .
Can prevent two generations from developing diabetes in the future.
Philippine CPG on Diagnosis & Screening for Gestational DiabetesIris Thiele Isip-Tan
Philippine CPG on diagnosis and screening of gestational diabetes presented for comments at the 3rd Unite for Diabetes Annual Convention this September.
Identifying women with GDM is important because appropriate therapy can decrease maternal and fetal morbidity .
Can prevent two generations from developing diabetes in the future.
Gestational diabetes mellitus (GDM) is one of the most common medical complications of pregnancy and is defined as glucose intolerance that first emerges or is first recognized during pregnancy. Gestational diabetes mellitus (GDM) affects between 2% and 5% of pregnant women. Data show that increasing levels of plasma glucose are associated with birth weight above the 90th percentile, cord blood serum C-peptide level above the 90th percentile, and, to a lesser degree, primary cesarean deliveries and neonatal hypoglycemia
Lecture held at the 4th Evidence-Based Neonatology conference, Nov 12 2017, in Hyderabad, India.
The lecture gives a short overview of the "fetal programming" theory, also referred to as the Developmental Origin of Health and Disease (DOHaD).
Over the past several years it has been proved that maternal thyroid disorder influence the outcome of mother and fetus, during and also after pregnancy. The most frequent thyroid disorder in pregnancy is maternal hypothyroidism. It is associated with fetal loss, placental abruptions, pre-eclampsia, preterm delivery and reduced intellectual function in the offspring.1 In pregnancy, overt hypothyroidism is seen in 0.2% cases2 and sub clinical hypothyroidism in 2.3% cases3. Fetal loss, fetal growth restriction, pre-eclampsia and preterm delivery are the usual complications of overt hyperthyroidism (low TSH and high T3, T4) seen in 2 of 1000 pregnancies whereas mild or sub clinical hyperthyroidism (suppressed TSH alone) is seen in
1.7% of pregnancies and not associated with adverse outcomes4. Autoimmune positive euthyroid pregnancy shows doubling of incidence of miscarriage and preterm delivery. Worldwide more than 20 million people develop neurological sequel due to intra uterine, iodine deprivation5. Other problems of thyroid disorders in pregnancy are post partum thyroiditis, thyroid nodules and cancer, hyper emesis gravidarum etc. Debates and disputes persist regarding several protocol and management plan in this specific spectrum of diseases.
SPACE 2015 - Conférence organisée par l'Institut de l'Elevage et co-présidée par Thomas Billé, Directeur du développement chez Celtilait Ouest Elevage, Matthieu Dupire, Responsable technique & Formulation chez LactalisFeed et Guillaume Jacques, Responsable technique et formation chez SofivoArmor Protéines
Gestational diabetes mellitus (GDM) is one of the most common medical complications of pregnancy and is defined as glucose intolerance that first emerges or is first recognized during pregnancy. Gestational diabetes mellitus (GDM) affects between 2% and 5% of pregnant women. Data show that increasing levels of plasma glucose are associated with birth weight above the 90th percentile, cord blood serum C-peptide level above the 90th percentile, and, to a lesser degree, primary cesarean deliveries and neonatal hypoglycemia
Lecture held at the 4th Evidence-Based Neonatology conference, Nov 12 2017, in Hyderabad, India.
The lecture gives a short overview of the "fetal programming" theory, also referred to as the Developmental Origin of Health and Disease (DOHaD).
Over the past several years it has been proved that maternal thyroid disorder influence the outcome of mother and fetus, during and also after pregnancy. The most frequent thyroid disorder in pregnancy is maternal hypothyroidism. It is associated with fetal loss, placental abruptions, pre-eclampsia, preterm delivery and reduced intellectual function in the offspring.1 In pregnancy, overt hypothyroidism is seen in 0.2% cases2 and sub clinical hypothyroidism in 2.3% cases3. Fetal loss, fetal growth restriction, pre-eclampsia and preterm delivery are the usual complications of overt hyperthyroidism (low TSH and high T3, T4) seen in 2 of 1000 pregnancies whereas mild or sub clinical hyperthyroidism (suppressed TSH alone) is seen in
1.7% of pregnancies and not associated with adverse outcomes4. Autoimmune positive euthyroid pregnancy shows doubling of incidence of miscarriage and preterm delivery. Worldwide more than 20 million people develop neurological sequel due to intra uterine, iodine deprivation5. Other problems of thyroid disorders in pregnancy are post partum thyroiditis, thyroid nodules and cancer, hyper emesis gravidarum etc. Debates and disputes persist regarding several protocol and management plan in this specific spectrum of diseases.
SPACE 2015 - Conférence organisée par l'Institut de l'Elevage et co-présidée par Thomas Billé, Directeur du développement chez Celtilait Ouest Elevage, Matthieu Dupire, Responsable technique & Formulation chez LactalisFeed et Guillaume Jacques, Responsable technique et formation chez SofivoArmor Protéines
This slides describe highlights of epidemiology of Gestational Diabetes Mellitus in Zagazig city , Egypt . Hoping in the future , more research will be hold to discover more facts about GDM in egypt.
Gestational diabetes is carbohydrate intolerance resulting in hyperglycaemia of variable severity with onset or first recognition during pregnancy (WHO). There are an estimated 4.5 million people living with diabetes in the UK (2). The estimated diabetes prevalence for adults between the ages of 20 and 70 worldwide was 415 million in 2015 and it is expected to affect 642 million people globally, by 2040 (1 in 10 people).
A cura di Federico Mecacci.
La gravidanza è un periodo molto bello della vita di una donna, ma non sempre le cose procedono senza problemi. Alcuni di questi sono particolarmente importanti e possono mettere a rischio la salute della mamma e del bambino. La Preeclampsia, che si manifesta con un aumento della pressione arteriosa e con la perdita di proteine nelle urine, ha un decorso rapidamente ingravescente, talora fulminante, e può danneggiare molti organi materni tra cui cervello, fegato, rene, cuore e sistema circolatorio. Spesso si accompagna a una grave alterazione del sistema della coagulazione, con seri rischi sia emorragici che trombotici. In più compromette quasi inevitabilmente la funzione della placenta e quindi la crescita ed il benessere del feto. Soprattutto nei casi ad esordio in epoche precoci della gravidanza, i danni feto-neonatali comportano disabilità permanenti a causa della prematurità.
È importante pertanto la diagnosi precoce unitamente alla sorveglianza clinica mirata a cogliere precocemente i segni di eventuali complicazioni, al fine di programmare il parto nel momento più opportuno sia per la madre che per il bambino.
Su queste basi questo corso, a più voci di Specialisti scelti in base al loro specifico expertise, si pone l'obiettivo di un aggiornamento del trattamento dell'Ipertensione in gravidanza sulle più recenti linee guida della International Society for the Study of Hypertension in Pregnancy ISSHP per il miglioramento dei sistemi di valutazione e di misurazione dell'efficienza e appropriatezza delle prestazioni nei livelli di assistenza.
Predizione e prevenzione della Preeclampsia - Adriana Valcamonicorobertobottino1
A cura di Adriana Valcamonico.
La gravidanza è un periodo molto bello della vita di una donna, ma non sempre le cose procedono senza problemi. Alcuni di questi sono particolarmente importanti e possono mettere a rischio la salute della mamma e del bambino. La Preeclampsia, che si manifesta con un aumento della pressione arteriosa e con la perdita di proteine nelle urine, ha un decorso rapidamente ingravescente, talora fulminante, e può danneggiare molti organi materni tra cui cervello, fegato, rene, cuore e sistema circolatorio. Spesso si accompagna a una grave alterazione del sistema della coagulazione, con seri rischi sia emorragici che trombotici. In più compromette quasi inevitabilmente la funzione della placenta e quindi la crescita ed il benessere del feto. Soprattutto nei casi ad esordio in epoche precoci della gravidanza, i danni feto-neonatali comportano disabilità permanenti a causa della prematurità.
È importante pertanto la diagnosi precoce unitamente alla sorveglianza clinica mirata a cogliere precocemente i segni di eventuali complicazioni, al fine di programmare il parto nel momento più opportuno sia per la madre che per il bambino.
Su queste basi questo corso, a più voci di Specialisti scelti in base al loro specifico expertise, si pone l'obiettivo di un aggiornamento del trattamento dell'Ipertensione in gravidanza sulle più recenti linee guida della International Society for the Study of Hypertension in Pregnancy ISSHP per il miglioramento dei sistemi di valutazione e di misurazione dell'efficienza e appropriatezza delle prestazioni nei livelli di assistenza.
Exposicion de Fisiopatologia e implicancias en el feto en la diabetes gestacional. Cobra importancia entender que el daño ocurre desde inicio del embarazo
BREVE PREMESSA:
Negli ultimi anni si sono sviluppate tecnologie altamente sofisticate che consentono di valutare il rischio per condizioni cromosomiche fetali. L'ampio ventaglio di opzioni oramai disponibili nell'ambito degli screening non invasivi pone numerosi quesiti su quale tecnologia utilizzare e le problematiche specifiche connesse alla tecnologia. Durante questa mezza giornata di aggiornamento verranno dunque presentate in modo semplificato le basi molecolari delle differenti tecnologie coi vantaggi e vantaggi correlati, quali test sono disponibili e il loro livello di certificazione in relazione alla normativa europea inerente alla marchiatura CE-IVD, quali sono le cause di risultati discordanti, dei ‘no results’ e la gestione dei casi con risultato ad alto rischio, no result e discordanze
OBIETTIVI FORMATIVI:
• Descrivere le differenti tecnologie disponibili coi relativi vantaggi e svantaggi;
• Presentare le cause biologiche dei risultati discordanti mediante cfDNA test;
• Illustrare le diverse cause di ‘no result’ e le implicazioni sulle performances del test;
• Descrivere l’utilità delle certificazioni, validazioni dei cfDNA test e dei controlli esterni di
qualità;
• Discutere circa l’utilità clinica dei contenuti aggiuntivi oltre alle trisomie 21,18,13;
• Discutere circa il follow-up e il management dei risultati ad alto rischio, dei no results e dei
risultati discordanti.
Presentation at the annual scientific conference of the DOST-National Research Council of the Philippines, 12 Mar 2024. Philippine International Convention Center, Manila.
Artificial Intelligence: Ethical Issues in Residency TrainingIris Thiele Isip-Tan
Symposium presentation at the annual convention of the Philippine Academy of Family Physicians, 8 March 2024. Philippine International Convention Center.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Evaluation of antidepressant activity of clitoris ternatea in animals
Gestational diabetes Q & A
1. 2 Mar 2012
GESTATIONAL DIABETES
MANAGEMENT
Iris Thiele Isip Tan MD, MSc, FPCP, FPSEM
Clinical Associate Professor, UP College of Medicine
Wednesday, November 21, 12
2. Q1
Which of the following
women will you screen for
gestational diabetes?
a) 25 y.o. G1P0 whose mother has
diabetes
b) 38 y.o. G3P0 with recurrent first-
trimester abortions
c) 27 y.o. G2P1
d) All of the above
Wednesday, November 21, 12
3. Unite for Diabetes CPG 2010
All pregnant women
should be screened for GDM.
Wednesday, November 21, 12
4. Risky
Filipino women are at increased
risk for diabetes in pregnancy.
ASGODIP Data n/N
Low risk 35/853
High risk 136/350
171/1203
Overall
14.2%
Litonjua AD et al. AFES Study Group on Diabetes in Pregnancy:
Preliminary Data on Prevalence. PJIM 1996:34:67-68.
Wednesday, November 21, 12
6. Risky
Cesearean Section Preeclampsia
Increased
risk of
maternal
morbidity
Pregnancy-induced hypertension Type 2 diabetes mellitus
http://www.flickr.com/photos/ulybug/512369383/
http://www.flickr.com/photos/j2dread/4501366303/
http://www.flickr.com/photos/78428166@N00/4921825364/
Wednesday, November 21, 12
7. International Diabetes
Federation (2009)
Global Guideline on
Pregnancy and Diabetes
“... women with GDM without risk
factors appear to be no different from
women with GDM and risk factors.”
Wednesday, November 21, 12
8. Q1
Which of the following
women will you screen for
gestational diabetes?
a) 25 y.o. G1P0 whose mother has
diabetes
b) 38 y.o. G3P0 with recurrent first-
trimester abortions
c) 27 y.o. G2P1
d) All of the above
Wednesday, November 21, 12
9. Q2
Which of the following factors
best predict risk of GDM?
a) prior history of GDM
b) glucosuria
c) family history of diabetes
d) prior macrosomic baby
Wednesday, November 21, 12
10. Prior history of GDM (OR 23.6 [95%CI 11.6, 48.0])3
Glucosuria (OR 9.04 [95%CI 2.6, 63.7]2; PPV 50% 4)
Family history of diabetes (OR 7.1 [95%CI 5.6, 8.9]1;
OR 2.74 [95%CI 1.47, 5.11]3)
Prior macrosomic baby (OR 5.59 [95%CI 2.68, 11.7])3
Age >25 years old (OR 1.9 [95%CI 1.3, 2.7]1; OR 3.37
[95%CI 1.45, 7.85]3)
Risk Factors for GDM
UNITE
CPG
Wednesday, November 21, 12
11. Diagnosis of polycystic ovary syndrome (OR 2.89
[95%CI 1.68, 4.98])5
Overweight or obese before pregnancy
(BMI >27 kg/m2 OR 2.3 [95%CI 1.6, 3.3]1; BMI>30 kg/
m2 OR 2.65 [95%CI 1.36, 5.14]3
Macrosomia in current pregnancy (PPV 40% 4)
Polyhydramnios in current pregancy (PPV 40% 4)
Intake of drugs affecting carbohydrate metabolism
Risk Factors for GDM
UNITE
CPG
Wednesday, November 21, 12
12. Q2
Which of the following factors
best predict risk of GDM?
a) prior history of GDM
b) glucosuria
c) family history of diabetes
d) prior macrosomic baby
Wednesday, November 21, 12
13. Q3
For pregnant women, when
should testing be done?
a) Test high-risk women at the soonest
possible time
b) Women without risk factors should be
tested between 24-28 wks AOG
c) Testing for gestational diabetes should still
be carried out in women at risk even beyond
24-28 wks AOG
d) All of the above
Wednesday, November 21, 12
14. ASGODIP (Veterans Memorial Medical Center)
AOG tested
% 21-30 31-40
<20 weeks
weeks weeks
n=19
n = 74 n = 60
Negative
95 92 85
for GDM
Positive
5 8 15
for GDM
Bihasa MTG et al. Screening for gestational diabetes: Report from ASGODIP
participating hospital: Veterans Memorial Medical Center. PJIM 1996:34:57-61.
Testing
Wednesday, November 21, 12
15. Q3
For pregnant women, when
should testing be done?
a) Test high-risk women at the soonest
possible time
b) Women without risk factors should be
tested between 24-28 wks AOG
c) Testing for gestational diabetes should still
be carried out in women at risk even beyond
24-28 wks AOG
d) All of the above
Wednesday, November 21, 12
16. Q4
Which test should be used to
screen for GDM?
a) 75-g OGTT
b) 100-g OGTT
c) 50-g GCT
d) FBS
Wednesday, November 21, 12
17. ★ Capillary blood glucose
★ RBS
★ Fructosamine
★ FBS
★ Hba1c
★ Urine glucose
NOT to be used
for diagnosis of GDM
Use
OGTT
Wednesday, November 21, 12
18. One-
step
50-g glucose Oral glucose
challenge tolerance test (OGTT)
test (GCT) 75-g or 100 g
“A one-stage definitive
procedure is preferred.”
International Diabetes Federation (2009)
Global Guideline on Pregnancy & Diabetes
Wednesday, November 21, 12
19. OGTT
100-g OGTT
high glucose
load often
unpalatable
100-g OGTT
duration
75-g OGTT
100-g more 3 hours
international
cumbersome;
standard in
4 blood
non-pregnant
samples
Wednesday, November 21, 12
20. CPG
Philippine Diabetes CPG has
endorsed the use of the 75-g OGTT.
Wednesday, November 21, 12
21. Q4
Which test should be used to
screen for GDM?
a) 75-g OGTT
b) 100-g OGTT
c) 50-g GCT
d) FBS
Wednesday, November 21, 12
22. Q5
Which of the following is true
of the OGTT procedure?
a) Low CHO intake for past 3 days
b) Fast for 10 to 16 h
c) Slow walking is not permitted
d) Supine position during test
Wednesday, November 21, 12
23. CHO intake of at least 150 g/day 3 days prior
Fast for 10 to 16 hours
75 grams of anhydrous dextrose powder as
chilled 25% solution (400 cc) flavored with
calamansi
Drink within 5 minutes (first swallow is time zero)
Terminate test should nausea and vomiting occur
Collect samples at 0, 1 and 2 hours
OGTT
Wednesday, November 21, 12
24. Abstain from tobacco, coffee, tea,
food and alcohol during test
Sit upright and quietly during the test
Slow walking is permitted but avoid
vigorous exercise
OGTT
Wednesday, November 21, 12
25. Q5
Which of the following is true
of the OGTT procedure?
a) Low CHO intake for past 3 days
b) Fast for 10 to 16 h
c) Slow walking is not permitted
d) Supine position during test
Wednesday, November 21, 12
26. Q6
Which of the following results
is/are consistent with GDM?
a) 75-g OGTT: FBS 90 1h 190 2h 150
b) 75-g OGTT: FBS 98 1h 190 2h 150
c) 100-g OGTT: FBS 98 1h 190 2h 150
3h 140
d) All of the above
Wednesday, November 21, 12
27. CPG
Thresholds ADA IADPSG
for
diagnosis 100-g 75-g 75-g*
FBS 95 95 92
1h 180 180 180
2h 155 155 153
3h 140 - -
* Requires only 1 threshold value exceeded
Wednesday, November 21, 12
28. Q6
Which of the following results
is/are consistent with GDM?
IADPSG
a) 75-g OGTT: FBS 90 1h 190 2h 150
ADA
b) 75-g OGTT: FBS 98 1h 190 2h 150
c) 100-g OGTT: FBS 98 1h 190 2h 150
3h 140 ADA
d) All of the above
Wednesday, November 21, 12
29. CPG
Thresholds ADA IADPSG
for
diagnosis 100-g 75-g 75-g*
FBS 95 95 92
1h 180 180 180
2h 155 155 153
3h 140 - -
* Requires only 1 threshold value exceeded
Wednesday, November 21, 12
30. OGTT
ACOG recommends against
IADPSG consensus
Diagnosis of GDM based on the 1-step
screening and diagnosis test outlined in the
IADPSG guidelines is not recommended at
this time because there is no evidence that diagnosis
using these criteria leads to clinically significant
improvement in maternal or newborn outcomes, and it
would lead to a significant increase in healthcare costs.
ACOG Committee on Obstetric Practice. Screening & Diagnosis of
Gestational Diabetes Mellitus. Obstetrics & Gynecology 2011; 118(3):751-3
Wednesday, November 21, 12
31. Q7
Which of the following is TRUE of
dietary management for GDM?
a) Do NOT prescribe less than 1500 cal/day for
multiple pregnancy
b) For overweight women, reduce energy
intake by no more than 30% of habitual intake
c) Monitor urine ketones at bedtime to detect
starvation ketonuria
d) Non-caloric sweeteners are NOT allowed.
Wednesday, November 21, 12
32. Diet
Recommended Daily
Caloric Intake
Pregravid BMI Category kcal/kg/day
Low (BMI <18.5 kg/m2) 36-40
Normal (BMI 18.5-24.9 kg/m2) 30
High (BMI 25-29.9 kg/m2) 24
Obese (BMI >29.9 kg/m2) 12
Jovanovic L (Ed). Medical Management of Pregnancy Complicated by Diabetes (2009)
Wednesday, November 21, 12
33. Diet
For considerably overweight women
with GDM, reduce energy intake by no
more than 30% of habitual intake
Total cal/day = 1,800-2,000
Not less than 2,000 cal/day if multiple
pregnancy
International Diabetes Federation (2009)
Global Guideline on Pregnancy and Diabetes
Wednesday, November 21, 12
34. “Non-c aloric sweeteners may
be used in moderation.”
ADA GDM Position Statement 2004
Wednesday, November 21, 12
35. Q7
Which of the following is TRUE of
dietary management for GDM?
a) Do NOT prescribe less than 1500 cal/day for
multiple pregnancy
b) For overweight women, reduce energy
intake by no more than 30% of habitual intake
c) Monitor urine ketones at bedtime to detect
starvation ketonuria
d) Non-caloric sweeteners are NOT allowed.
Wednesday, November 21, 12
36. Q8
For a woman with normal BMI,
what is the allowed weight gain
in pregnancy?
a) <28-40 lbs
b) 25-35 lbs
c) 15-25 lbs
d) 11-20 lbs
Wednesday, November 21, 12
37. Weight gain during pregnancy
12.5 kg British cohort of >3800 primigravidae
eating without restriction
Product of conception
Fetus, placenta, amniotic fluid
Maternal tissue expansion
Uterus, breasts, blood volume
Maternal fat reserve
Text
Wednesday, November 21, 12
38. Rates of weight gain*
Prepregnancy Total weight
2nd and 3rd
BMI gain (lbs)
trimester (lbs/week)
Underweight 1
<28-40
BMI <18.5 (1-1.3)
Normal weight 1
25-35
BMI 18.5-24.9 (0.8-1)
Overweight 0.6
15-25
BMI 25.0-29.9 (0.5-0.7)
Obese 0.5
11-20
BMI >30.0 (0.4-0.6)
* Assume a 0.5-2.0 kg (1.1-4.4 lbs)
weight gain in the first trimester
IOM
Wednesday, November 21, 12
39. Q8
For a woman with normal BMI,
what is the allowed weight gain
in pregnancy?
a) <28-40 lbs
b) 25-35 lbs
c) 15-25 lbs
d) 11-20 lbs
Wednesday, November 21, 12
40. Q9
Which of the following is TRUE of
self-monitoring of blood glucose?
a) For women on dietary intervention alone,
monitor BG 6x a day.
b) For women treated with insulin, postprandial
monitoring is superior to pre-prandial.
c) If on insulin, test BG before breakfast to detect
hypoglycemia.
d) Daily SMBG does not appear to be superior to
intermittent office monitoring.
Wednesday, November 21, 12
41. “For women treated with insulin, limited
evidence indicates that postprandial
monitoring is superior to preprandial
monitoring.” ADA GDM Position Statement 2004
Wednesday, November 21, 12
42. Diet only
Monitor BG 4x a day (prebreakfast and 1 h
after the first bite of food at each meal)
AACE 2007
Wednesday, November 21, 12
43. Q9
Which of the following is TRUE of
self-monitoring of blood glucose?
a) For women on dietary intervention alone,
monitor BG 6x a day. 3x a day
b) For women treated with insulin, postprandial
monitoring is superior to pre-prandial.
c) If on insulin, test BG before breakfast to detect
hypoglycemia. Test at night
d) Daily SMBG does not appear to be superior to
intermittent office monitoring.
Wednesday, November 21, 12
44. Q10
What are the targets for
SMBG?
a) Between 60 to 90 mg/dL for fasting and less
than 120 mg/dL 1 hour after the first bite of food
at each meal (postprandial)
b) Not more than 95 mg/dL for fasting and less
than 120 mg/dL 2 hours postprandial
c) 90 mg/dL for fasting and less than 140 mg/dL
2 hours postprandial
d) None of the above
Wednesday, November 21, 12
45. Between 60 to 90 mg/dL (fasting) and
less than 120 mg/dL (1 hour after the
first bite of food at each meal)
AACE 2007
Wednesday, November 21, 12
46. Q10
What are the targets for
SMBG?
a) Between 60 to 90 mg/dL for fasting and less
than 120 mg/dL 1 hour after the first bite of food
at each meal (postprandial)
b) Not more than 95 mg/dL for fasting and less
than 120 mg/dL 2 hours postprandial
c) 90 mg/dL for fasting and less than 140 mg/dL
2 hours postprandial
d) None of the above
Wednesday, November 21, 12
47. Q11
Can we give Metformin
for GDM?
a) Yes
b) No
Wednesday, November 21, 12
48. ★ Use of Metformin or glibenclamide
during pregnancy NOT an approved
indication
★ Discuss with patients
★ Obtain and document informed consent.
Canadian Diabetes Association 2008
METFORMIN: Off-label use
OHA
Wednesday, November 21, 12
49. Insulin remains the
agent of choice
“In poorly resourced areas
of the world, the
theoretical disadvantages
of using oral glucose-
lowering agents ... far less
than the risks of non-
treatment.” IDF 2009
Insulin
Wednesday, November 21, 12
50. Q11
Can we give Metformin
for GDM?
a) Yes
b) No
Wednesday, November 21, 12
51. Q12
When and how should insulin
be started in GDM?
a) Consider insulin when diet and exercise fail to
maintain glucose targets in 1-2 weeks
b) Ultrasound shows incipient fetal macrosomia
(AC >70th percentile)
c) Start daily insulin at 0.1-0.3 u/kg BW
d) All of the above
Wednesday, November 21, 12
52. Insulin Initiation
ADA Protocol
Fasting whole BG >95 mg/dL
1-h postprandial whole BG >140 mg/dL
2-h postprandial whole BG >120 mg/dL
Dr. Jovanovic
Fasting plasma glucose >90 mg/dL (5 mmol/L)
1-h PP whole BG >120 mg/dL (6.7 mmol/L)
Insulin
Jovanovic L (Ed). Medical Management of Pregnancy Complicated by Diabetes (2009)
Wednesday, November 21, 12
53. Q12
When and how should insulin
be started in GDM?
a) Consider insulin when diet and exercise fail to
maintain glucose targets in 1-2 weeks
b) Ultrasound shows incipient fetal macrosomia
(AC >70th percentile)
c) Start daily insulin at 0.1-0.3 u/kg BW
d) All of the above
Wednesday, November 21, 12
54. Q13
Which of the following is true of
management during labor?
a) Give dextrose-containing IV fluids
b) Give short-acting insulin for CBG>140 mg/dL
c) Check CBG q hourly.
d) All of the above
Wednesday, November 21, 12
55. Protocol for Spontaneous Delivery
Infusion of 500 ml 5% dextrose/saline
x4h
CBG q 4h
Give short-acting insulin for CBG >140
mg/dL
L
- Do se equal to mmol of CBG i.e. 12 u for 12 mmol/
u for
- Dose equal to 1/20th of mg/dL of CBG i.e. 12
240 mg/dL
Omit insulin for CBG <140 mg/dL
ASGODIP
Wednesday, November 21, 12
56. After delivery
Resume diet
GDMs with high insulin requirements
during pregnancy should have
glucose profiles
Give insulin if BG persistently high
(>200 mg/dL)
ASGODIP
Wednesday, November 21, 12
57. Q13
Which of the following is true of
management during labor?
a) Give dextrose-containing IV fluids
b) Give short-acting insulin for CBG>140 mg/dL
c) Check CBG q hourly.
d) All of the above
Wednesday, November 21, 12
58. Q14
Which of the following is true of
postpartum follow-up?
a) Schedule 75-g OGTT 6 weeks after follow-up
b) Measure FBS every 3 years
c) Advise patient not to get pregnant again
d) Breastfeeding should be limited
Wednesday, November 21, 12
59. Jovanovic L (Ed). Medical Management of
Pregnancy Complicated by Diabetes (2009)
Annual follow-up
Measure FBS
Assess weight reduction
Review pregnancy plans
Wednesday, November 21, 12
60. Ff-up
All patients with prior GDM
should be educated re:
lifestyle modifications
Maintain normal body weight:
MNT and physical activity
Women with IFG or IGT
postpartum: intensive MNT and
individualized exercise program
ADA GDM Position Statement 2004
Wednesday, November 21, 12
61. Ff-up
Planning subsequent
pregnancies
Plan future pregnancies in
consultation with health
care provider
Assess glucose tolerance
prior to conception to
assure normoglycemia at
time of conception
Canadian Diabetes Association 2008
Wednesday, November 21, 12
62. Q14
Which of the following is true of
postpartum follow-up?
a) Schedule 75-g OGTT 6 weeks after follow-up
b) Measure FBS every 3 years
c) Advise patient not to get pregnant again
d) Breastfeeding should be limited
Wednesday, November 21, 12
63. Thank You
http://www.endocrine-witch.net
@endocrine_witch
Image from http://wthr.frumph.net/
Wednesday, November 21, 12